382 related articles for article (PubMed ID: 36107314)
1. Nuclear Receptors and Lipid Sensing.
Thorne JL; Cioccoloni G
Adv Exp Med Biol; 2022; 1390():83-105. PubMed ID: 36107314
[TBL] [Abstract][Full Text] [Related]
2. Nuclear receptors and nonalcoholic fatty liver disease.
Cave MC; Clair HB; Hardesty JE; Falkner KC; Feng W; Clark BJ; Sidey J; Shi H; Aqel BA; McClain CJ; Prough RA
Biochim Biophys Acta; 2016 Sep; 1859(9):1083-1099. PubMed ID: 26962021
[TBL] [Abstract][Full Text] [Related]
3. Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunity.
Kidani Y; Bensinger SJ
Immunol Rev; 2012 Sep; 249(1):72-83. PubMed ID: 22889216
[TBL] [Abstract][Full Text] [Related]
4. Gaining weight: the Keystone Symposium on PPAR and LXR.
Lehrke M; Pascual G; Glass CK; Lazar MA
Genes Dev; 2005 Aug; 19(15):1737-42. PubMed ID: 16077002
[TBL] [Abstract][Full Text] [Related]
5. The Role of Lipid Sensing Nuclear Receptors (PPARs and LXR) and Metabolic Lipases in Obesity, Diabetes and NAFLD.
Dixon ED; Nardo AD; Claudel T; Trauner M
Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33926085
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro.
Downie MM; Sanders DA; Maier LM; Stock DM; Kealey T
Br J Dermatol; 2004 Oct; 151(4):766-75. PubMed ID: 15491415
[TBL] [Abstract][Full Text] [Related]
7. Regulation of calcific vascular and valvular disease by nuclear receptors.
Sallam T; Tintut Y; Demer LL
Curr Opin Lipidol; 2019 Oct; 30(5):357-363. PubMed ID: 31369409
[TBL] [Abstract][Full Text] [Related]
8. The emerging role of constitutive androstane receptor and its cross talk with liver X receptors and peroxisome proliferator-activated receptor A in lipid metabolism.
Xiao L; Wang J; Jiang M; Xie W; Zhai Y
Vitam Horm; 2013; 91():243-58. PubMed ID: 23374719
[TBL] [Abstract][Full Text] [Related]
9. PPARs and other nuclear receptors in inflammation.
Rizzo G; Fiorucci S
Curr Opin Pharmacol; 2006 Aug; 6(4):421-7. PubMed ID: 16777482
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.
Latruffe N; Vamecq J
Biochimie; 1997; 79(2-3):81-94. PubMed ID: 9209701
[TBL] [Abstract][Full Text] [Related]
11. Anthranilic acid derivatives as nuclear receptor modulators--development of novel PPAR selective and dual PPAR/FXR ligands.
Merk D; Lamers C; Weber J; Flesch D; Gabler M; Proschak E; Schubert-Zsilavecz M
Bioorg Med Chem; 2015 Feb; 23(3):499-514. PubMed ID: 25583100
[TBL] [Abstract][Full Text] [Related]
12. Nuclear receptors as drug targets for metabolic disease.
Schulman IG
Adv Drug Deliv Rev; 2010 Oct; 62(13):1307-15. PubMed ID: 20655343
[TBL] [Abstract][Full Text] [Related]
13. Integration of metabolism and inflammation by lipid-activated nuclear receptors.
Bensinger SJ; Tontonoz P
Nature; 2008 Jul; 454(7203):470-7. PubMed ID: 18650918
[TBL] [Abstract][Full Text] [Related]
14. The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology.
Kiss M; Czimmerer Z; Nagy L
J Allergy Clin Immunol; 2013 Aug; 132(2):264-86. PubMed ID: 23905916
[TBL] [Abstract][Full Text] [Related]
15. Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome.
Vacca M; Degirolamo C; Mariani-Costantini R; Palasciano G; Moschetta A
Wiley Interdiscip Rev Syst Biol Med; 2011; 3(5):562-87. PubMed ID: 21755605
[TBL] [Abstract][Full Text] [Related]
16. Lipid ligand-activated transcription factors regulating lipid storage and release in human macrophages.
Chinetti-Gbaguidi G; Staels B
Biochim Biophys Acta; 2009 Jun; 1791(6):486-93. PubMed ID: 19416654
[TBL] [Abstract][Full Text] [Related]
17. Modulation of xenobiotic nuclear receptors in high-fat diet induced non-alcoholic fatty liver disease.
Li X; Wang Z; Klaunig JE
Toxicology; 2018 Dec; 410():199-213. PubMed ID: 30120929
[TBL] [Abstract][Full Text] [Related]
18. PPARs and LXRs: atherosclerosis goes nuclear.
Barish GD; Evans RM
Trends Endocrinol Metab; 2004; 15(4):158-65. PubMed ID: 15109614
[TBL] [Abstract][Full Text] [Related]
19. Dietary phosphate restriction induces hepatic lipid accumulation through dysregulation of cholesterol metabolism in mice.
Tanaka S; Yamamoto H; Nakahashi O; Kagawa T; Ishiguro M; Masuda M; Kozai M; Ikeda S; Taketani Y; Takeda E
Nutr Res; 2013 Jul; 33(7):586-93. PubMed ID: 23827134
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-alpha enhances lipid metabolism in a skin equivalent model.
Rivier M; Castiel I; Safonova I; Ailhaud G; Michel S
J Invest Dermatol; 2000 Apr; 114(4):681-7. PubMed ID: 10733673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
